Introduction
The 2-[ [1] [2] [3] . The mechanism and biochemical pathway of FDG uptake in cancer cells has been extensively studied both in vitro [4] and in vivo [5, 6] . [ 18 F]FDG, which is an analog of D-glucose (GLU), is taken up into cells through the cell membrane through sodiumindependent glucose transport (GLUT) proteins [7, 8] , and is then phosphorylated to [ 18 F]FDG-6-phosphate by hexokinase inside the cell [9, 10] .
Glucose transport into mammalian cells is accomplished by two classes of transporters: sodium-dependent GLUTs (SGLTs) and facilitative GLUTs. SGLTs consist of 14 transmembrane domains, and six subtypes (SGLT1-SGLT6) of SGLTs have been identified [11] . The family of facilitative GLUTs comprises 13 members (GLUT1-GLUT13) [12] . The expression levels of SGLTs and GLUTs have been shown to differ between certain tumor and normal cells. The SGLTs and GLUTs display a polarized distribution in renal proximal tubule cells that have an apical Na + -glucose cotransport system [13, 14] that involves SGLTs [15, 16] and a basolateral Na + -independent facilitated diffusion system that involves GLUTs [17, 18] .
A model of the glucose transport systems in the proximal tubule of kidney epithelial LLC-PK 1 cell line derived from pig is shown in Fig. 1 . This cell line has been useful for studying the polarized distribution of the transcellular transporters SGLTs and/or GLUTs [15, [19] [20] [21] . Thus, this cell line exhibits a basolateral Na + -independent GLUT-1 system for sugar efflux [15, 19] and an apical SGLT-1 system for Na + -glucose entry [15, [20] [21] [22] . GLUT-1 is the only GLUT isoform that has been detected in LLC-PK 1 cells. In addition to SGLTs and GLUT-1, LLC-PK 1 cells also express other transporters typical of kidney proximal tubules such as organic anion transporters (OATs) [23] and organic cation transporters (OCTs) [24] , on both the apical and basolateral sides of the cell. OATs and OCTs are believed to be important for kidney function as they have extremely broad substrate selectivity and their substrates include not only endogenous anions and cations but also several clinically important drugs [25, 26] .
In clinical studies, elimination of [ 18 F]FDG through the urine interferes with the visualization of both urologic diseases around the pelvis and abdominal abnormalities. In an earlier study using rats, phlorizin (PHZ), an SGLT inhibitor, improved urinary excretion of [ 18 F]FDG [27] . However, as many transporters reside on the apical and basolateral sides of the proximal tubules, other transporters besides SGLT may also be associated with transcellular transport of [ , membrane pore size: 3 mm) in Transwell cell chambers. The volume of medium inside and outside the Transwell chamber was approximately 0.5 and 1.5 ml, respectively. The medium was replaced with fresh medium every 2 days. The cells were used 4-6 days after harvesting. 
Materials and methods
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Transport systems in the kidney epithelial LLC-PK 1 cell line. The transporters that were assayed for transcellular transport of [
18 F]FDG included the sodium-dependent glucose transporter (SGLT), the sodium-independent glucose transporter (GLUT), the organic anion transporter (OAT), and the organic cation transporter (OCT). The white and gray circles indicate high and moderate transporter expression levels, respectively. 
Outline of transport experiments using the LLC-PK 1 cell line. LLC-PK 1 cells were grown as a monolayer on a permeable support in a Transwell cell chamber. [ Transcellular transport between LLC-PK 1 cells, grown in Transwell chambers, was investigated according to the scheme illustrated in Fig. 2 4 were replaced with choline chloride and K 2 HPO 4 , respectively. For transport studies, the culture medium was removed from both sides of the cell monolayer and the cell monolayer was first preincubated with 0.5 ml PBS( + ) or PBS( -) on the apical side and with 1.5 ml PBS( + ) or PBS( -) on the basolateral side for 10 min at 371C. After preincubation, [ 3 H]mannitol were added to the incubation medium of the apical or the basolateral side. The inhibitors, PHZ, PHT, probenecid, and tetraethylammonium bromide, were also added at a final concentration of 0.1 mmol/l in PBS( + ) concomitantly with each tracer addition. For transport measurements, an aliquot (50 ml) of the incubation medium from the opposite side of the cell to which the tracer had been added was obtained at 10, 30, 60, and 90 min after the start of the tracer incubation, and the radioactivity of each sample was measured. An LSC-51000 liquid scintillation counter (Aloka) was used to determine the 14 C and 3 H radioactivity of the collected incubation media as well as that of the cell monolayer that was solubilized using 0.5 ml of 1 N NaOH.
Statistical analysis
Measurements are expressed as means ± SD. Statistical analyses were performed using an unpaired t-test. Probability values were 0.01 or 0.05 (P < 0.01, 0.05).
Results
The transcellular transport of [ ]GLU were shown using black bars and white bars, respectively. Inhibitors used were: Phlorizin (PHZ), phloretin (PHT), probenecid (PBC) and tetraethylammonium bromide (TEA) that predominantly inhibit sodium-dependent glucose transporters (SGLTs), sodium-independent glucose transporters (GLUTs), organic anion transporters (OATs) and organic cation transporters (OCTs), respectively. Transport was assessed at 10 min of incubation in phosphate-buffered saline (+) with or without each inhibitor and paracellular flux was corrected for using D-[ 3 H]mannitol. Each point represents the mean ± SD (n = 4 monolayers).
w P < 0.01 and *P < 0.05, significant differences between control and inhibitor for [ 14 ]GLU (white bars) was assayed as described in the legend to Fig. 4 , except that the incubation time was for 90 min. PBC, probenecid; PHT, phloretin; PHZ, phlorizin; TEA, tetraethylammonium bromide. w P < 0.01 and *P < 0.05, significant differences between control and inhibitor for [ 14 (P < 0.05). The effect of the inhibitors over 30-90 min of incubation showed a similar trend to that observed at 90 min of incubation.
Discussion
We have characterized the renal transcellular transport (reabsorption and secretion) of FDG in the kidney proximal tubules using a well-established in-vitro model, the LLC-PK 1 cell line, as well as inhibitors of specific transporters and multiple assay time points for comparison with GLU transport. Although there are many transporters in the renal proximal tubules, to date only the use of an SGLT inhibitor has been reported to increase the excretion of [
18 F]FDG in the urine [31] . Our study did not include an assay of amino acid transporters that have been proposed to transport [ (Fig. 4) . Reabsorption of GLU, but not FDG, by GLUT is consistent with earlier reported results that substitution of a hydroxy group at the second position of GLU with a fluorine atom modulates its ability to be transported by the glucose carrier [33] . Therefore, FDG will be transported only by SGLT and not by GLUT, resulting in substantially greater urinary excretion of [ GLU. This could potentially be because of a lower specificity of these transporters for FDG and GLU. On account of the described effects of PHT, FDG was reabsorbed through SGLT at early time points after the administration of PHT, whereas GLU was reabsorbed through SGLT and GLUT over the entire incubation time after the administration of PHT administration. Although neither tracer showed high secretion mediated by a specific transporter, the secretion of FDG was higher than that of GLU. ]FDG in a clinical study, kidney reabsorption could be decreased and urinary excretion promoted. This effect has been shown in an earlier rat study [25] . That is, GLUT mainly mediates the uptake of [ 
